Targeted therapy for drug-tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours.
Ishida T, Takahashi T, Kurokawa Y, Nishida T, Hirota S, Serada S, Fujimoto M, Naka T, Teranishi R, Saito T, Yamashita K, Tanaka K, Yamamoto K, Makino T, Yamasaki M, Nakajima K, Eguchi H, Doki Y.
Ishida T, et al. Among authors: teranishi r.
Br J Cancer. 2021 Nov;125(11):1511-1522. doi: 10.1038/s41416-021-01566-9. Epub 2021 Oct 5.
Br J Cancer. 2021.
PMID: 34611306
Free PMC article.